Media Summary: When Gary was diagnosed with cancer, his doctors recommended a clinical trial. Hear his story in the latest video by "You can't just sit back and be a spectator. You have to get into the fight and be a participant in this journey that we're all on. Go behind the scenes and "Meet the Scientist" with Allison Marlow, PhD, a medical writer and scientist at

Array Biopharma Adds 10 On - Detailed Analysis & Overview

When Gary was diagnosed with cancer, his doctors recommended a clinical trial. Hear his story in the latest video by "You can't just sit back and be a spectator. You have to get into the fight and be a participant in this journey that we're all on. Go behind the scenes and "Meet the Scientist" with Allison Marlow, PhD, a medical writer and scientist at Clinical trial participant Gary meets scientist Allison Marlow, PhD, in this "Meet the Scientist" video from

Photo Gallery

Array BioPharma Adds 10% on Positive Study Data for ARRY-520
PropThink Interviews: Array BioPharma
Why Pfizer Is Buying Array BioPharma for $10.6 Billion
Array Biopharma waiting on approval for skin cancer drugs
Pfizer acquires array biopharma in $10.64B deal
Meet Gary - Array BioPharma
Meet Anne - Array BioPharma
Pfizer buys Array Biopharma for $48/share in cash
Meet the Scientist - Array BioPharma
Science Meets Gratitude - Array BioPharma
News Update: Array BioPharma, Inc. to Develop Anti-Cancer Drug with Novartis AG
Pfizer will access Array's approved cancer drugs in $11 billion deal
View Detailed Profile
Array BioPharma Adds 10% on Positive Study Data for ARRY-520

Array BioPharma Adds 10% on Positive Study Data for ARRY-520

Array BioPharma

PropThink Interviews: Array BioPharma

PropThink Interviews: Array BioPharma

Ron Squarer, Chief Executive of

Why Pfizer Is Buying Array BioPharma for $10.6 Billion

Why Pfizer Is Buying Array BioPharma for $10.6 Billion

Jun.17 -- Pfizer Inc. will buy

Array Biopharma waiting on approval for skin cancer drugs

Array Biopharma waiting on approval for skin cancer drugs

Array Biopharma

Pfizer acquires array biopharma in $10.64B deal

Pfizer acquires array biopharma in $10.64B deal

Pfizer is buying

Meet Gary - Array BioPharma

Meet Gary - Array BioPharma

When Gary was diagnosed with cancer, his doctors recommended a clinical trial. Hear his story in the latest video by

Meet Anne - Array BioPharma

Meet Anne - Array BioPharma

"You can't just sit back and be a spectator. You have to get into the fight and be a participant in this journey that we're all on.

Pfizer buys Array Biopharma for $48/share in cash

Pfizer buys Array Biopharma for $48/share in cash

Dow component Pfizer is buying

Meet the Scientist - Array BioPharma

Meet the Scientist - Array BioPharma

Go behind the scenes and "Meet the Scientist" with Allison Marlow, PhD, a medical writer and scientist at

Science Meets Gratitude - Array BioPharma

Science Meets Gratitude - Array BioPharma

Clinical trial participant Gary meets scientist Allison Marlow, PhD, in this "Meet the Scientist" video from

News Update: Array BioPharma, Inc. to Develop Anti-Cancer Drug with Novartis AG

News Update: Array BioPharma, Inc. to Develop Anti-Cancer Drug with Novartis AG

Array BioPharma

Pfizer will access Array's approved cancer drugs in $11 billion deal

Pfizer will access Array's approved cancer drugs in $11 billion deal

Dow component Pfizer is buying

News Update: Analyst Downgrades Array BioPharma, Inc; Shares Plummet (NASDAQ:ARRY)

News Update: Analyst Downgrades Array BioPharma, Inc; Shares Plummet (NASDAQ:ARRY)

Following